|

JNJ-101556143 Formulation 3 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Janssen Research & Development, LLC1

Indications

  • Prostate Cancer Metastatic Disease1
  • Metastatic Prostate Cancer1
  • Prostate Cancer (Adenocarcinoma)1
  • Cancer1

Colorado Springs, Colorado1 trial

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

Rocky Mountain Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.